Products, developed to market:
Haemopressin® (active ingredient: terlipressin) for treatment
of esophageal varices bleeding.
2. Cortirel® (active ingredient: human corticorelin) for differential diagnosis of pituitary-adrenal function.
Haemopressin® was purchased in 2006 by Sinclair IS Pharma, London and Chester, United Kingdom.
Acetylated Glucagon-like Peptide-1(7-34) Amide. [Ac-GLP-1 (7-34 Amide)] is a long-acting GLP-1 receptor agonist, licensed from Pharis Biotec GmbH, Hannover, Germany for exclusive world-wide development and marketing. Ac-GLP-1 (7-34) Amide (Curaglutide) is in pre-clinical development.
|Ac-GLP-1(7-34) amide, Patent EP 1 012 188|
|John H et al. 2008|